Discovery of potential biomarkers for human atherosclerotic abdominal aortic aneurysm through untarg

• 作 者: Lei JI Siliang CHEN Guangchao GU Wei WANG Jinrui REN Fang XU Fangda LI Jianqiang WU Dan YANG Yuehong ZHENG
• 机 构: Department of Vascular Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Scie
• 出 处: 浙江大学学报（英文版）（B辑：生物医学和生物技术）
• 发表日期: 2021年9期
• 关键词: Abdominal aortic aneurysm (AAA) Atherosclerosis (AS) Untargeted metabolomics Tra

Abdominal aortic aneurysm (AAA) and atherosclerosis (AS) have considerable similarities in clinical risk factors and molecular pathogenesis. The aim of our study was to investigate the differences between AAA and AS from the perspective of metabolomics, and to explore the potential mechanisms of differential metabolites via integration analysis with transcriptomics. Plasma samples from 32 AAA and 32 AS patients were applied to characterize the metabolite profiles using untargeted liquid chromatography-mass spectrometry (LC-MS). A total of 18 remarkably different metabolites were identified, and a combination of seven metabolites could potentially serve as a biomarker to distinguish AAA and AS, with an area under the curve (AUC) of 0.93. Subsequently, we analyzed both the metabolomics and transcriptomics data and found that seven metabolites, especially 2\'-deoxy-D-ribose (2dDR), were significantly correlated with differentially expressed genes. In conclusion, our study presents a comprehensive landscape of plasma metabolites in AAA and AS patients, and provides a research direction for pathogenetic mechanisms in atherosclerotic AAA.